{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:08:36Z","timestamp":1783350516065,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11596-020-2211-3","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T15:13:11Z","timestamp":1594998791000},"page":"539-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K\/AKT, Ras\/ERK and JAK1\/STAT3 Signaling Pathways in CCl4-induced Liver Fibrosis Rats"],"prefix":"10.1007","volume":"40","author":[{"given":"Hou-gang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-tao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-jun","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-ci","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-min","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-ying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-xiong","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"issue":"33","key":"2211_CR1","first-page":"87","volume":"33","author":"D Rockey","year":"2006","unstructured":"Rockey D, Friedman S. Hepatic Fibrosis and Cirrhosis. Dig Dis, 2006, 33(33):87\u2013109","journal-title":"Dig Dis"},{"issue":"2","key":"2211_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest, 2005, 115(2):209\u2013218","journal-title":"J Clin Invest"},{"issue":"3","key":"2211_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.fct.2005.08.003","volume":"44","author":"JY Liu","year":"2006","unstructured":"Liu JY, Chen CC, Wang WH, et al. The protective effects of Hibiscus sabdariffa extract on CCl4-induced liver fibrosis in rats. Food Chem Toxicol, 2006, 44(3):336\u2013343","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"2211_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jep.2009.12.011","volume":"127","author":"QL Wang","year":"2010","unstructured":"Wang QL, Yuan LJ, Tao YY, et al. Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-\u03b21-induced epithelial-to-mesenchymal transition. J Ethnopharmacol, 2010, 127(3):631\u2013640","journal-title":"J Ethnopharmacol"},{"key":"2211_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1749-8546-4-12","volume":"4","author":"C Liu","year":"2009","unstructured":"Liu C, Hu Y, Xu L, et al. Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med, 2009, 4:12","journal-title":"Chin Med"},{"key":"2211_CR6","unstructured":"Wang DM, Chang FR, Shen MQ, et al. Treatment of 60 Cases of Hepatitis B Virus Carrier with \u201cYuganlong\u201d and Its Experimental Study. Jiangsu J Tradit Chin Med (Chinese), 1999(08):45\u201346"},{"key":"2211_CR7","unstructured":"Cui XY, Zhang LJ. The clinical experience of treating 50 cases of hepatitis b with yuganlong oral liquid. Qinghai Med J (Chinese), 1998(12):44\u201345"},{"key":"2211_CR8","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.biopha.2018.07.081","volume":"106","author":"Y Xia","year":"2018","unstructured":"Xia Y, Yu B, Ma C, et al. Yu Gan Long reduces rat liver fibrosis by blocking TGF-\u03b21\/Smad pathway and modulating the immunity. Biomed Pharmacother, 2018, 106:1332\u20131338","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2211_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00996300","volume":"22","author":"RP Dirks","year":"1995","unstructured":"Dirks RP, Bloemers HP. Signals controlling the expression of PDGF. Mol Biol Rep, 1995, 22(1):1\u201324","journal-title":"Mol Biol Rep"},{"key":"2211_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijid.2016.06.004","volume":"49","author":"J Zhou","year":"2016","unstructured":"Zhou J, Deng Y, Yan L, et al. Serum platelet-derived growth factor BB levels: A potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B. Int J Infect Dis, 2016, 49:94\u201399","journal-title":"Int J Infect Dis"},{"issue":"1","key":"2211_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","volume":"53","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gao J, Zhang D, et al. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol, 2010, 53(1):132\u2013144","journal-title":"J Hepatol"},{"issue":"6","key":"2211_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/labinvest.3700094","volume":"84","author":"E Borkham-Kamphorst","year":"2004","unstructured":"Borkham-Kamphorst E, Herrmann J, Stoll D, et al. Dominant-negative soluble PDGF-receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Invest, 2004, 84(6):766\u2013777","journal-title":"Lab Invest"},{"issue":"125","key":"2211_CR13","first-page":"81","volume":"23","author":"R Peng","year":"2017","unstructured":"Peng R, Yuan Y. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K\/AKT\/mTOR\/p70S6K1 signaling pathways. Discov Med, 2017, 23(125):81\u201394","journal-title":"Discov Med"},{"issue":"2","key":"2211_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jhep.2010.10.040","volume":"55","author":"X Wang","year":"2010","unstructured":"Wang X, Ikejima K, Kon K, et al. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells. J Hepatol, 2010, 55(2):379\u2013387","journal-title":"J Hepatol"},{"issue":"4","key":"2211_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","volume":"130","author":"D Calvisi","year":"2006","unstructured":"Calvisi D, Ladu S, Gorden A, et al. Ubiquitous Activation of Ras and Jak\/Stat Pathways in Human HCC. Gastroenterology, 2006, 130(4):1117\u20131128","journal-title":"Gastroenterology"},{"issue":"6","key":"2211_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s11064-015-1567-4","volume":"40","author":"Z Yu","year":"2015","unstructured":"Yu Z, Tang L, Chen L, et al. Capillarisin Suppresses Lipopolysaccharide-Induced Inflammatory Mediators in BV2 Microglial Cells by Suppressing TLR4-Mediated NF-\u03baB and MAPKs Signaling Pathway. Neurochem Res, 2015, 40(6):1095\u20131101","journal-title":"Neurochem Res"},{"key":"2211_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.biopha.2017.09.037","volume":"95","author":"J Lu","year":"2017","unstructured":"Lu J, Zhong Y, Lin Z, et al. Baicalin alleviates radiation-induced epithelial-mesenchymal transition of primary type II alveolar epithelial cells via TGF-\u03b2 and ERK\/GSK3\u03b2 signaling pathways. Biomed Pharmacother, 2017, 95:1219\u20131224","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2211_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12890-016-0294-1","volume":"16","author":"X Huang","year":"2016","unstructured":"Huang X, He Y, Chen Y, et al. Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-\u03b21-induced ERK1\/2 signaling pathway. BMC Pulm Med, 2016, 16(1):132","journal-title":"BMC Pulm Med"},{"key":"2211_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jep.2015.03.068","volume":"168","author":"C Ma","year":"2015","unstructured":"Ma C, Zhu L, Wang J, et al. Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K\/Akt\/mTOR signaling pathway. J Ethnopharmacol, 2015, 168:349\u2013355","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"2211_CR20","doi-asserted-by":"publisher","first-page":"9648","DOI":"10.1002\/jcb.28243","volume":"120","author":"C Ma","year":"2019","unstructured":"Ma C, Zou L, Xia Y, et al. Extracts of Coleus forskohlii relieves cough and asthma symptoms via modulating inflammation and the extracellular matrix. J Cell Biochem, 2019, 120(6):9648\u20139655","journal-title":"J Cell Biochem"},{"issue":"5","key":"2211_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2613.2007.00543.x","volume":"88","author":"R Smyth","year":"2007","unstructured":"Smyth R, Munday Michael R, York Malcolm J, et al. Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat. Int J Exp Pathol, 2007, 88(5):361\u2013376","journal-title":"Int J Exp Pathol"},{"issue":"12","key":"2211_CR22","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.fct.2006.06.025","volume":"44","author":"T Jayakumar","year":"2006","unstructured":"Jayakumar T, Ramesh E, Geraldine P. Antioxidant activity of the oyster mushroom, Pleurotus ostreatus, on CCl4-induced liver injury in rats. Food Chem Toxicol, 2006, 44(12):1989\u20131996","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"2211_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","volume":"37","author":"G Carpino","year":"2005","unstructured":"Carpino G, Morini S, Ginannicorradini S, et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis, 2005, 37(5):349\u2013356","journal-title":"Dig Liver Dis"},{"issue":"8","key":"2211_CR24","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta, 2007, 1773(8):1263\u20131284","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2211_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0098-2997(00)00004-2","volume":"21","author":"G Poli","year":"2000","unstructured":"Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med, 2000, 21(3):49\u201398","journal-title":"Mol Aspects Med"},{"issue":"9","key":"2211_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.4254\/wjh.v7.i9.1209","volume":"7","author":"B Hu","year":"2015","unstructured":"Hu B, Wang SS, Du Q. Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside. World J Hepatol, 2015, 7(9):1209\u20131232","journal-title":"World J Hepatol"},{"key":"2211_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","volume":"28","author":"E Borkham-Kamphorst","year":"2016","unstructured":"Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev, 2016, 28:53\u201361","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"2211_CR28","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","volume":"147","author":"S Yoshida","year":"2014","unstructured":"Yoshida S, Ikenaga N, Liu SB, et al. Extrahepatic platelet-derived growth factor-beta, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology, 2014, 147(6):1378\u20131392","journal-title":"Gastroenterology"},{"issue":"1","key":"2211_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","volume":"10","author":"JAD Campo","year":"2018","unstructured":"Campo JAD, Gallego P, Grande L. Role of inflammatory response in liver diseases: Therapeutic strategies. World J Hepatol, 2018, 10(1):1\u20137","journal-title":"World J Hepatol"},{"issue":"5","key":"2211_CR30","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1172\/JCI66369","volume":"123","author":"C Yin","year":"2013","unstructured":"Yin C, Evason KJ, Asahina K, et al. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest, 2013, 123(5):1902\u20131910","journal-title":"J Clin Invest"},{"key":"2211_CR31","first-page":"1","volume":"31","author":"J Ahn","year":"2018","unstructured":"Ahn J, Chae HS, Chin YW, et al. Furylhydroquinones and miscellaneous compounds from the roots of Lithospermum erythrorhizon and their anti-inflammatory effect in HaCaT cells. Nat Prod Res, 2018, 31:1\u20138","journal-title":"Nat Prod Res"},{"issue":"3","key":"2211_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bcp.2011.11.002","volume":"83","author":"EJ Park","year":"2012","unstructured":"Park EJ, Chun JN, Kim SH, et al. Schisandrin B suppresses TGF\u03b21 signaling by inhibiting Smad2\/3 and MAPK pathways. Biochem Pharmacol, 2012, 83(3):378\u2013384","journal-title":"Biochem Pharmacol"},{"key":"2211_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.02.007","volume":"187","author":"AM Kidger","year":"2018","unstructured":"Kidger AM, Sipthorp J, Cook SJ. ERK1\/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1\/2-ERK1\/2 pathway. Pharmacol Ther, 2018, 187:45\u201360","journal-title":"Pharmacol Ther"},{"issue":"1\u20132","key":"2211_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tox.2011.01.009","volume":"282","author":"NP Foo","year":"2011","unstructured":"Foo NP, Lin SH, Lee YH, et al. \u03b1-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-\u03b2. Toxicology, 2011, 282(1\u20132):39\u201346","journal-title":"Toxicology"},{"issue":"5","key":"2211_CR35","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/hep.23186","volume":"50","author":"G Son","year":"2009","unstructured":"Son G, Hines I, Lindquist J, et al. Inhibition of Phosphatidylinositol 3-Kinase Signaling in Hepatic Stellate Cells Blocks the Progression of Hepatic Fibrosis. Hepatology, 2009, 50(5):1512\u20131523","journal-title":"Hepatology"},{"issue":"6","key":"2211_CR36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2010.12.013","volume":"54","author":"AC Piguet","year":"2011","unstructured":"Piguet AC, Dufour JF. PI(3)K\/PTEN\/AKT pathway. J Hepatol, 2011, 54(6):1317\u20131319","journal-title":"J Hepatol"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-020-2211-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-020-2211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:45:15Z","timestamp":1626479115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-020-2211-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1007\/s11596-020-2211-3","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"9 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}